Washington. Healthcare. Translated.


High-Impact Drugs: Is “Impact” on patients or payers?

I caught a report from OptumRx of “Five Drugs Set to Have the Biggest Impact on Payers and Patients.” It’s ...
Read More

Acthar Gel: from 10,000 Feet

There’s a lot of attention going to Acthar Gel and how Medicaid has stripped it of its favorable rebate status, ...
Read More

Acthar Gel: Do Huge Price Hikes (Always) Make Drugmakers Evil?

Both the general press and the trade press have delighted in predicting great injury (if not even death) to Mallinckrodt ...
Read More

Devices: Start with Coverage, or Reimbursement?

The world of launching a new healthtech product is outrageously complicated in our era. Even large and sophisticated devicemakers can ...
Read More